152 related articles for article (PubMed ID: 19770023)
21. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
22. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
23. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
24. [Interaction of blood sex steroid-binding globulin with cell membranes of human decidual tissue].
Avvakumov GV; Survilo LI; Strel'chenok OA
Biokhimiia; 1985 Jul; 50(7):1155-61. PubMed ID: 4041494
[TBL] [Abstract][Full Text] [Related]
25. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
[TBL] [Abstract][Full Text] [Related]
26. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
[TBL] [Abstract][Full Text] [Related]
27. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
28. Conjugated estrogens and breast cancer risk.
Campagnoli C; Ambroggio S; Biglia N; Sismondi P
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():13-9. PubMed ID: 10862264
[TBL] [Abstract][Full Text] [Related]
29. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
30. Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines.
Schobert R; Bernhardt G; Biersack B; Bollwein S; Fallahi M; Grotemeier A; Hammond GL
ChemMedChem; 2007 Mar; 2(3):333-42. PubMed ID: 17266159
[TBL] [Abstract][Full Text] [Related]
31. O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.
Raineri M; Catalano MG; Hammond GL; Avvakumov GV; Frairia R; Fortunati N
Mol Cell Endocrinol; 2002 Mar; 189(1-2):135-43. PubMed ID: 12039072
[TBL] [Abstract][Full Text] [Related]
32. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants of sex hormone-binding globulin and their biological consequences.
Xita N; Tsatsoulis A
Mol Cell Endocrinol; 2010 Mar; 316(1):60-5. PubMed ID: 19733622
[TBL] [Abstract][Full Text] [Related]
34. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
36. Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid.
Ben-Rafael Z; Mastroianni L; Meloni F; Lee MS; Flickinger GL
J Clin Endocrinol Metab; 1986 Nov; 63(5):1106-11. PubMed ID: 3093520
[TBL] [Abstract][Full Text] [Related]
37. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).
Fortunati N; Fissore F; Fazzari A; Piovano F; Catalano MG; Becchis M; Berta L; Frairia R
J Steroid Biochem Mol Biol; 1999; 70(1-3):73-80. PubMed ID: 10529004
[TBL] [Abstract][Full Text] [Related]
38. The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer.
Becchis M; Frairia R; Ferrera P; Fazzari A; Ondei S; Alfarano A; Coluccia C; Biglia N; Sismondi P; Fortunati N
Breast Cancer Res Treat; 1999 Mar; 54(2):101-7. PubMed ID: 10424400
[TBL] [Abstract][Full Text] [Related]
39. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
[TBL] [Abstract][Full Text] [Related]
40. Sex hormone-binding globulin and estrogen receptor in breast cancer: technique and preliminary clinical results.
Murayama Y; Sakuma T; Udagawa H; Utsunomiya J; Okamoto R; Asano K
J Clin Endocrinol Metab; 1978 Jun; 46(6):998-1006. PubMed ID: 263661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
